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Edited by Sandro SonninoAbstract The mechanisms underlying regional amyloid b-pro-
tein (Ab) deposition in brain remain unclear. Here we show that
assembly of hereditary variant Dutch- and Italian-type Abs, and
Flemish-type Ab was accelerated by GM3 ganglioside, and GD3
ganglioside, respectively. Notably, cerebrovascular smooth mus-
cle cells, which compose the cerebral vessel wall at which the
Dutch- and Italian-type Abs deposit, exclusively express GM3
whereas GD3 is upregulated in the co-culture of endothelial cells
and astrocytes, which forms the cerebrovascular basement mem-
brane, the site of Flemish-type Ab deposition. Our results sug-
gest that regional Ab deposition is induced by the local
gangliosides in the brain.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Several mutations within the amyloid b-protein (Ab) se-
quence have been reported to be responsible for the develop-
ment of familial Alzheimers disease (AD) and hereditary
cerebral amyloid angiopathy [1–3]. The Arctic-type (E22G)
and Dutch-type (E22Q) mutations show distinct phenotypes
of Ab amyloidosis in the brain; the former induces Ab deposi-
tion in the brain parenchyma [3] whereas the latter causes Ab
deposition predominantly in the cerebral vessel wall [1,4].
Thus, it is reasonable to assume that the area-speciﬁc deposi-
tion of these Ab variants in the brain is facilitated by as yet
undetermined local environmental factors.
Recently, we have found that the Arctic-type Ab, but not the
Dutch-type Ab, rapidly assembles in the presence of GM1 gan-Abbreviations: Ab, amyloid b-protein; AD, Alzheimers disease;
HCSM, human cerebrovascular smooth muscle; TLC, thin layer
chromatography; CTX, cholera toxin subunit B
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doi:10.1016/j.febslet.2005.03.013glioside (GM1) [5], suggesting that GM1 plays a critical role in
the induction of Ab deposition in the brain parenchyma.
Meanwhile, we previously observed that the Dutch-type Ab
rapidly assembles on the surface of cultured human cerebro-
vascular smooth muscle (HCSM) cells [6,7]. Regarding the
pathology caused by the Flemish-type (A21G) mutation, pre-
vious studies clearly demonstrated that this variant Ab starts
to deposit on the outer surface of cerebral vessels, including
capillary which lacks HCSM cells, suggesting that one of the
components of the cerebrovascular basement membrane but
not of the cerebral vessel wall induces the Flemish-type Ab
assembly [8]. Interestingly, previous studies indicated that
GD3 ganglioside (GD3) is preferentially localized in the peri-
vascular area [9].
This line of evidence led us to hypothesize that assembly
of hereditary Ab variants is accelerated by local environmen-
tal factors, e.g., the presence of particular gangliosides in
brain.2. Materials and methods
2.1. Materials
GM1, GM2, GD1a, GD1b and GT1b gangliosides were purchased
from Wako (Osaka, Japan). GM3 ganglioside (GM3) and GD3 were
purchased from HyTest (Turku, Finland). GT3 ganglioside was pro-
vided by Dr. S. Ando. Standard gangliosides for thin layer chromatog-
raphy (TLC) and GM4 ganglioside were isolated from a bovine brain
and cock small intestine [10]. Synthetic Abs (Ab1–40) (wild-type and
variant forms) were purchased from Peptide Inst. (Osaka, Japan).
Anti-Ab monoclonal antibody (4G8), anti-GM1 polyclonal antibody
(anti-GM1), anti-GM3 monoclonal antibody (GMR6), anti-GD3
monoclonal antibody (R24), anti-CD31 polyclonal antibody (H-300)
and anti-glial ﬁbrillary acidic protein (GFAP) polyclonal antibody
(Z0334) were purchased from Signet Laboratories (Dedham, MA),
Calbiochem (San Diego, CA), Seikagaku Co. (Tokyo, Japan), Calbio-
chem, Dako (Kyoto, Japan), and Santa Cruz Biotechnology (Santa
Cruz, CA), respectively. Horseradish peroxidase (HRP) and cholera
toxin subunit B (CTX) were purchased from Sigma–Aldrich (St. Louis,
MO).2.2. Incubation of Ab solutions and thioﬂavin T (ThT) assay
The seed-free Ab solutions, which were prepared as described else-
where [11], were incubated at 50 lM, pH 7.4, and 37 C for 24 h or
as indicated in the ﬁgures, in the presence or absence of liposomes con-
taining gangliosides at concentration of 250 lM as previously reported
[12]. ThT assay was performed as described elsewhere [11].blished by Elsevier B.V. All rights reserved.
Fig. 1. Assembly of hereditary Ab variants in the presence of particular gangliosides. (A) ThT ﬂuorescence intensities of the Ab solutions incubated
in the presence of various gangliosides. The ThT ﬂuorescence intensities of the solutions containing Ab alone or liposomes alone were negligible (data
not shown). Each column indicates mean ± S.D. of four values. \P < 0.0001 versus the value of the wild-type Ab (one-way ANOVA combined with
Sheﬀes test). (B) Kinetics of Ab assembly. The Ab solutions were incubated in the presence or absence of liposomes containing gangliosides. The
ThT ﬂuorescence intensity was obtained by excluding background activity at 0 h. (C) Electron micrographs of the Ab solutions incubated in the
presence of gangliosides. Bars, 50 nm. (D) Western blot of the insoluble Ab assemblies. Ab solutions incubated in the presence or absence of
gangliosides were ultracentrifuged and the precipitates were subjected to Western blot analysis following solubilization in formic acid. The blot was
reacted with 4G8.
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The Ab solutions incubated at 50 lM with various liposomes at a
ganglioside: Ab molar ratio of 5:1 for 24 h at 37 C, and then, centri-
fuged at 540000 · g for 15 min. The precipitates were subjected to
Western blot analysis following solubilization in formic acid as previ-
ously described [13].
2.4. Cell culture
The primary cultures of HCSM cells were prepared as previously de-
scribed [14]. Human brain microvascular endothelial cells and human
brain astrocytes were purchased from Dainippon Pharmaceutical Inc.
(Osaka, Japan). Cells were cultured on collagen-coated ﬂask in CS-C
medium (Dainippon Pharmaceutical Inc.) in humidiﬁed 5% CO2 at
37 C. Cells were harvested after 1 week in culture.
2.5. Lipid analysis of cultured cells
Total lipid of the cultured cells was extracted with chloroform–meth-
anol (2:1, v/v). The ganglioside fraction was prepared as previously de-
scribed [15]. Gangliosides (2–10 lg as free sialic acid) were applied to
TLC plates (E. Merck) and developed with chloroform–methanol–
water (5:4:1, v/v/v; solvent A) and chloroform–methanol–2.5 N
NH4OH (5:4:1, v/v/v; solvent B). The gangliosides were separated in
the ﬁrst dimension (upward) with solvent A and in the second dimen-
sion (to the left) with solvent B. The gangliosides were detected with
resorcinol/HCl reagent.
2.6. Immunocytochemistry
Cultured cells were ﬁxed with acetone and incubated with blocking
solution containing 5% goat serum and 5% donkey serum in phos-
phate-buﬀered saline (PBS) (Cosmo Bio Co., Tokyo, Japan). The cells
were then incubated overnight at 4 C with an anti-GM1 polyclonal
antibody (anti-GM1) (1:200), an anti-GM3 monoclonal antibody
(GMR6) (1:100), an anti-GD3 monoclonal antibody (R24) (1:250) or
an anti-CD31 polyclonal antibody (H-300) (1:200) in PBS containing
1% BSA. The cells were also incubated with these antibodies or an
anti-GFAP polyclonal antibody (Z0334) (1:500) for 1 h at room tem-
perature following permeabilization with 0.1% Triton X-100. After
washing with PBS, the cells were further incubated with a rhoda-
mine-conjugated antibody (1:200) for GM1, GM3 and GD3 staining
or with an Alexa 488-conjugated antibody (1:200) for CD31 and
GFAP staining, respectively.Fig. 2. GM3 expression by HCSM cells and GM3 requirement by the
Italian-type Ab for its assembly. (A) Determination of ganglioside
species expressed by HCSM cells. Gangliosides extracted from HCSM
cells were separated by two-dimensional TLC. STD: standard. Arrows
1, 2, 3, 4, 5, 6 and 7 indicate GM3, GM2, GM1, GD1a, GD1b, GT1b
and GQ1b, respectively. (B) ThT ﬂuorescence intensities of the
solutions of the Italian-type Ab incubated in the presence of various
gangliosides. The ThT ﬂuorescence intensities of the solutions
containing Ab alone or liposomes alone were negligible (data not
shown). Each column indicates mean ± S.D. of four values.
\P < 0.0001 versus the value of incubation with GM1 (one-way
ANOVA combined with Sheﬀes test).3. Results
3.1. Requirement of gangliosides by the hereditary Ab variants
for their assembly
We incubated the hereditary Ab variants with a-, b- and c-
series of gangliosides, including GM1, GM2, GM3, GM4,
GD1a, GD1b, GD3, GT1b and GT3. In this experiment, the
ﬂuorescence intensity of ThT, which speciﬁcally recognizes
amyloid ﬁbrillar structure, of the Arctic-type Ab solution
markedly increased in the presence of GM1 as we have recently
reported [5] (Fig. 1A). In contrast, the ThT ﬂuorescence inten-
sity of the Dutch-type Ab solution increased the most in the
presence of GM3, and to a lesser extent, in the presence of
GM2 (Fig. 1A). Moreover, the ThT ﬂuorescence intensity of
the Flemish-type Ab solution exclusively increased in the pres-
ence of GD3 (Fig. 1A). To conﬁrm that the ThT ﬂuorescence
intensity of these Ab solutions speciﬁcally increases in the
presence of particular gangliosides, we performed a kinetic
study. The ThT ﬂuorescence intensity of the solutions of the
Arctic-, Dutch- and Flemish-type Abs increased in the presence
of GM1, GM3 and GD3, respectively, in a time-course-
dependent manner (Fig. 1B). Electron microscopy revealed
the formation of amyloid ﬁbrils in solutions of the Arctic-,
Dutch- and Flemish-type Abs in the presence of GM1, GM3
and GD3, respectively (Fig. 1C). Furthermore, Western blotanalysis showed that the insoluble assemblies of the Arctic-,
Dutch- and Flemish-type Abs were preferentially formed in
the presence of GM1, GM3 and GD3, respectively (Fig. 1D).
3.2. Expression of GM3 by HCSM cells
We performed TLC of the extract of HCSM cells and ob-
served an exclusive appearance of GM3 and, to a lesser extent,
of GM2 (Fig. 2A). Taken together with the requirement of
GM3 and GM2 by the Dutch-type Ab for its assembly
(Fig. 1), it seems reasonable to assume that these gangliosides
induce the assembly and deposition of this particular variant
Ab in the cerebral vessel wall. To further support this notion,
we investigated whether the assembly of the Italian-type Ab
(E22K), another well-known hereditary Ab variant which
selectively deposits in the cerebral vessel wall [16], requires
these gangliosides for its assembly. Notably, the ThT ﬂuores-
cence intensity of the Italian-type Ab solution exclusively in-
creased in the presence of GM3 but not of GM2 (Fig. 2B).
3.3. Expression of GD3 by the astrocytes co-cultured with
endothelial cells
We investigated whether GD3 is expressed in the co-culture
of endothelial cells and astrocytes, which forms the cerebrovas-
cular basement membrane [17]. Dot blot analysis of the cell
2188 N. Yamamoto et al. / FEBS Letters 579 (2005) 2185–2190lysates revealed that GD3 was markedly upregulated in the co-
culture (Fig. 3A). We also performed immunocytochemistry
on these co-cultured cells and found that GD3 preferentially
appeared on the processes of the astrocytes that were in direct
contact with the endothelial cells (Fig. 3B). Importantly,
immunoreactivities of GM1 and GM3 were not detected in
the co-culture unless the cells were pretreated for permeabiliza-
tion (Fig. 3B). We then examined whether the GD3 expression
on the surface on the processes of the astrocytes was suﬃcient
to induce assembly of the Flemish-type Ab. Notably, the exog-
enous Flemish-type Ab, but not the wild-type and other vari-
ant forms of Ab, assembled in the co-culture of these cellsFig. 3. GD3 expression in the co-culture of endothelial cells and astrocytes.
and co-culture of these cells. 0.5 lg protein of the lysates were blotted. The
ligand speciﬁc to GM1 or antibodies against GM3 (GMR6) and GD3 (R2
astrocytes and the co-culture of these cells, respectively. (B) Immunocytochem
cells. The endothelial cells and astrocytes were immunostained with antibo
culture of the endothelial cells and astrocytes were immunostained with both
antibody against GD3 (R24). The co-culture was also immunostained w
permeabilization. Arrows (1) and (2) indicate endothelial cells and astrocyte, r
(C) Assembly of the exogenous Flemish-type Ab in the co-culture of the en
added to the culture of the endothelial cells, astrocytes and co-culture of th
Arctic- and Dutch-type Abs were also exogenously added to the co-culture. T
50 lm.(Fig. 3C). Furthermore, the Flemish-type Ab assembly in the
co-culture was substantially suppressed by the co-incubation
with an anti-GD3 antibody (R24) (Fig. 3C).4. Discussion
A fundamental question about the pathogenesis of AD con-
cerns how Ab assembles and deposits in the brain. We previ-
ously identiﬁed a novel Ab species, which is characterized by
its tight binding to GM1, in the AD brain [18]. On the basis
of the unique molecular characteristics of GM1-bound Ab(A) Dot blot of the lysates of the cultured endothelial cells, astrocytes
blots were incubated with HRP-conjugated CTX, which is a natural
4). E, A and C indicate the culture of endothelial cells, the culture of
istry of the cultured endothelial cells, astrocytes and co-culture of these
dies against CD31 (H-300) and GFAP (Z0334), respectively. The co-
H-300 and Z0334. The cells were also double-immunostained with an
ith anti-GM1 or GMR6 with (insets) or without pretreatment for
espectively. Arrowheads indicate the process of astrocyte. Bars, 50 lm.
dothelial cells and astrocytes. The Flemish-type Ab was exogenously
ese cells with or without an antibody against GD3 (R24). The wild-,
he Ab assemblies in the culture were visualized with thioﬂavin-S. Bar,
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logenesis [18]. This study, together with previous in vitro and
in vivo studies [12,19–22], further supports our hypothesis,
and also, for the ﬁrst time, provides a likely contributing factor
for the area-speciﬁc deposition of the hereditary Ab variants
[1,3,4,8,16,23]. Here we show that the assembly of hereditary
Ab variants is accelerated in the presence of speciﬁc ganglio-
sides that are predominantly expressed at the respective sites
of preferential deposition of the hereditary Ab variants in
the brain. Although further studies are needed, it may be pos-
sible to conclude that local gangliosides play a critical role in
the area-speciﬁc assembly and deposition of the hereditary
Ab variants.
Gangliosides are found at highest concentrations in brain;
however, it remains to be clariﬁed whether a given ganglioside
is expressed in an area-speciﬁc manner in the brain. In the
present study, HCSM cells and astrocytes in direct contact
with endothelial cells predominantly expressed GM3 and
GD3, respectively. In contrast to the possible area-speciﬁc
expression of GM3 and GD3, GM1 is expressed rather
broadly in brain, at least, beyond the preferential site of Ab
deposition [24]. Thus, it remains to be clariﬁed how GM1 is in-
volved in the acceleration of the assembly of the wild- and Arc-
tic-type Abs preferably in the parenchyma of cerebral cortex.
One of the possible explanations is that the local quantity of
GM1 increases in the AD brain as we indicated in the aged
apolipoprotein-E4-knock-in mouse brain [13]. Notably, this
possibility has been supported by recent study of AD brains
[25]. The future challenges will be to determine how ganglio-
sides expression, in conjunction with other area-speciﬁc fac-
tors, leads to regional Ab accumulation.
Regarding biophysical basis for the binding between Ab and
gangliosides, a previous study suggested that sialic acid resi-
dues are crucial for the binding [19]. However, we previously
found that the conformational alteration of Ab following its
binding to gangliosides was not dependent on the number of
the sialic acid residues but rather on the ganglioside species
[26]. From the results of this study, we may conclude that
the structure of oligosaccharide chain of gangliosides is a
determinant for the generation of seed Abs. However, it re-
mains to be elucidated how diﬀerences between the ganglio-
sides are responsible for the Ab-species-dependent
conformational alteration.
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